RECITALSTermination of License Agreement • December 12th, 1997 • Ic Isaacs & Co Inc • Knit outerwear mills
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL SETTLEMENT AND TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • May 11th, 2023 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
This Settlement and Termination of License Agreement (the “Settlement Agreement”) is made as of May 12, 2022 (the “Settlement Effective Date”), by and between Aytu BioPharma, Inc. (formerly known as Aytu BioScience, Inc.), a Delaware corporation, with its principal offices at 373 Inverness Parkway, Suite 206, Englewood, CO (“Aytu”), and TRIS Pharma, Inc., a New Jersey corporation, with a location at 2031 U.S. Highway 130, Monmouth Junction, NJ 08852 (“TRIS”) (collectively, the “Parties”).
TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • March 7th, 2024 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Termination of License Agreement (this “Agreement”) is made and entered into as of March 1, 2024 by and between Carna Biosciences, Inc., a corporation organized under the laws of Japan (“Carna”) and Fresh Tracks Therapeutics, Inc. (f/k/a Brickell Biotech, Inc.), a Delaware corporation (“FRTX”).
Termination of License AgreementTermination of License Agreement • March 4th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Early Termination of License Agreement (“Termination Agreement”) is dated February 28, 2022 (“Execution Date”) and is entered into by and between Yumanity, Inc., previously known as, Yumanity Therapeutics, Inc., (“Licensee”) and MIL 40, LLC (“Licensor”).
